Group items tagged

India has a massive pool of top bone marrow transplant specialist in India who is proficient and well-researched in delivering the best treatments to our patients.

India is a prime destination for liver transplants due to its excellent medical teams and liver transplant hospitals with affordable price in India compared to other developed countries.

There are some of the top 10 cornea transplant surgeons of India when it comes to eye care treatment India is the best destination to undergo your eye transplant surgery performed.

Liver transplant in India is excellent and affordable because the country is boasted enough resources, hospital infrastructure, and skilled doctors.

The kidney transplant surgery cost in India is significantly lower compared to Western countries, while still maintaining one of the highest success rates globally.

Top 10 bone marrow transplant hospitals in India are dedicated to providing treatment to both domestic and international medical tourists at reasonable prices.

The cost of liver cirrhosis transplant in India is just a fraction of what it is in the US, UK, and other developed nations.

The bone marrow transplant cost India provides a combination of top-notch professionals and extensive hematological expertise.

The liver transplant surgery cost in India is around 50% less than the cost of similar procedures in Western countries.

The low cost of eye cornea transplants in India is cheap compared to other countries in the world that provide the same type of healthcare and services.

Health authorities in India have said that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's Covishield, from Friday (Aug 12). Corbevax will be available to over 18s as precautionary booster six months after a second dose, the health ministry said in an August 8 letter to state authorities. Covishield is produced for the Indian market by the Serum Institute of India under licence from AstraZeneca, while Bharat Biotech makes Covaxin. India has so far administered more than 2 billion Covid vaccine shots, including 113 million boosters, all of which have so far been of the same vaccine as the recipient's first two doses. The government says about 89 per cent of Indians above the age of 12 have had two doses.

Doctor at best hospitals for eye transplant surgery India told me that I would have to undergo a transplant again as there has been deterioration in the outermost layer of the cornea.

Low cost kidney transplant in India is much low as compared to international hospitals so Indian hospitals attract most of the international patients.

The top 10 cornea transplant surgeons in India are recognized for retaining strict protection standards which include accomplishing multiple tests for eye readability.

The bone marrow transplant top hospitals of India offer the combination of the best professionals along with experienced hematological experience.

Indian drugmaker Dr Reddy's Laboratories will launch its generic version of Merck's antiviral Covid-19 pill, molnupiravir, and price it at 35 rupees ($0.4693) per capsule, a company spokesperson said on Tuesday (January 4). The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to 1,400 rupees ($18.77). In comparison, the treatment with Merck's pill in the United States costs $700. "Molflu is expected to be available from early next week in pharmacies throughout (India) with particular focus on states with high caseload of Covid-19," the company spokesperson said. India last week gave emergency use approval to along with two vaccines, as the country braces for a possible spike in coronavirus cases due to the rapidly spreading Omicron variant.

India's top liver transplant surgeons are renowned for their expertise and vast experience in the field. They have received rigorous training and specialization from leading global institutions, ensuring they stay at the forefront of medical advancements and techniques.

India will make tests mandatory for cough syrups before they are exported, a government notice showed on Tuesday, after Indian-made cough syrups were linked to the deaths of dozens of children in Gambia and Uzbekistan. Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, the government said in a notice dated May 22 and shared by the health ministry on Tuesday. India's $41 billion pharmaceutical industry is one of the biggest in the world but its reputation was shaken after the World Health Organization (WHO) found toxins in cough syrups made by three Indian companies. Syrups made by two of these companies were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year. "Cough syrup shall be permitted to be exported subject to the export sample being tested and production of certificate of analysis," said the notice issued by the trade ministry. The health ministry did not immediately respond to a query on whether testing would be required for cough syrups sold in the domestic market.

India is a globally renowned medical destination it's a favorite of global sufferers looking for low-cost healthcare, which incorporates blood marrow transplants, past their domestic land.

Indian authorities have cancelled or suspended licences of some domestic drug companies as part of action taken against 76 pharmaceutical firms this month for selling adulterated or fake products, a government source said on Thursday. India is known as the 'pharmacy of the world' and its pharmaceuticals exports have more than doubled over the past decade to $24.5 billion in 2021-22. But that image has been dented by the death of at least 70 children in Gambia and 19 children in Uzbekistan in Uzbekistan last year linked to drugs made by India-based pharmaceutical companies. Health Minister Mansukh Mandaviya confirmed a crackdown but did not give details of companies against which action had been taken. "There are more than 10,500 pharma companies in the country. Companies who make spurious medicine will not be spared," Mandaviya told reporters at an event. Licences of some Indian drug companies have been cancelled, some were suspended while others have been put on notice during the past 15 days, the source, who had direct knowledge of the matter, told Reuters news agency.